Britannia Life Sciences Inc.
BLSIF
$0.04
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -895.80K | -1.47M | -1.51M | -1.51M | -1.02M |
| Total Depreciation and Amortization | 62.30K | 61.80K | 61.20K | 61.20K | 71.70K |
| Total Amortization of Deferred Charges | 33.90K | 33.90K | 33.90K | 33.90K | -- |
| Total Other Non-Cash Items | 67.10K | 940.30K | 1.19M | 1.19M | 351.90K |
| Change in Net Operating Assets | 14.30K | 166.40K | 795.90K | 795.90K | 1.10M |
| Cash from Operations | -718.30K | -270.60K | 570.10K | 806.80K | 735.60K |
| Capital Expenditure | -9.00K | -9.00K | -9.00K | -9.00K | -4.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -687.00K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.88M | -314.10K | -196.40K | -196.40K | -140.20K |
| Cash from Investing | -3.88M | -323.10K | -205.40K | -336.70K | -963.20K |
| Total Debt Issued | 0.00 | 771.50K | 771.50K | 771.50K | 771.50K |
| Total Debt Repaid | -634.60K | -627.80K | -619.10K | -619.10K | -526.10K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -554.90K | -1.05M | -1.05M | -1.05M |
| Cash from Financing | -454.00K | -290.40K | -648.80K | -1.07M | -1.01M |
| Foreign Exchange rate Adjustments | -2.00K | 27.90K | 41.60K | 41.60K | 82.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.06M | -856.20K | -242.40K | -534.30K | -1.13M |